Biodexa Pharmaceuticals (BDRX) Stock Chart & Stock Price History $3.85 +0.23 (+6.35%) (As of 09:15 AM ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesSEC FilingsShort InterestTrends Biodexa Pharmaceuticals Stock Price Performance 5 Day Performance-25.36%1 Month Performance-36.49% Receive BDRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address The only candlestick pattern worth a darn (Ad)It’s widely known that 80% of daily market action is driven by Wall Street algorithms… Now, most people think of the algorithms are “bad” When in reality, they are neither good nor bad… They are simply programmed to buy and sell certain stocks over and over again… But here is the thing… They are predictable… They typically buy the same stocks at the same levels over and over again…Follow this link here and enter your email address to sign up… BDRX Stock Chart for Monday, November, 18, 2024 BDRX Chart by TradingView Biodexa Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/15/2024$4.86$3.62-25.51%$4.80$3.5164,761 shs$185,000.0011/14/2024$4.85$4.86+0.21%$5.00$4.857,586 shs$243,000.0011/13/2024$5.03$4.85-3.58%$5.08$4.7019,136 shs$242,000.0011/12/2024$5.18$5.03-2.90%$5.45$5.0334,483 shs$257,000.0011/11/2024$5.38$5.18-3.72%$5.58$5.1421,006 shs$264,000.0011/08/2024$5.47$5.38-1.65%$5.50$5.2620,031 shs$274,000.00 Get the Latest News and Ratings for BDRX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/07/2024$5.78$5.47-5.36%$5.91$5.1599,462 shs$279,000.0011/06/2024$5.63$5.78+2.66%$6.06$5.6219,320 shs$290,000.0011/05/2024$5.68$5.63-0.88%$5.90$5.6218,402 shs$282,000.0011/04/2024$5.91$5.68-3.89%$5.89$5.688,267 shs$290,000.0011/01/2024$6.15$5.91-3.90%$6.31$5.54102,232 shs$296,000.0010/31/2024$6.20$6.15-0.81%$6.47$6.1122,643 shs$314,000.0010/30/2024$6.66$6.20-6.91%$6.66$6.1727,465 shs$316,000.0010/29/2024$6.51$6.66+2.30%$6.72$6.2028,428 shs$333,000.0010/28/2024$6.31$6.51+3.17%$6.84$6.2051,868 shs$8.38 million10/25/2024$6.62$6.31-4.61%$7.23$6.26215,431 shs$316,000.0010/24/2024$7.07$6.62-6.44%$7.08$6.5547,201 shs$8.51 million10/23/2024$6.24$7.07+13.30%$7.45$6.01136,777 shs$9.10 million10/22/2024$5.98$6.24+4.35%$6.43$5.6182,341 shs$8.03 million10/21/2024$5.70$5.98+4.91%$6.25$5.5670,287 shs$7.70 million10/18/2024$5.87$5.70-2.90%$6.40$5.55160,443 shs$7.34 million10/17/2024$8.40$5.87-30.12%$6.77$5.50473,590 shs$7.56 million Related Companies PaxMedica Stock Chart Qualigen Therapeutics Stock Chart Histogen Stock Chart PolarityTE Stock Chart Cyclacel Pharmaceuticals Stock Chart TC Biopharm Stock Chart Ignyte Acquisition Stock Chart Bellerophon Therapeutics Stock Chart Elevai Labs Stock Chart PainReform Stock Chart Receive BDRX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Biodexa Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BDRX) was last updated on 11/18/2024 by MarketBeat.com Staff From Our Partners“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purpose...Priority Gold | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredFREE investing Class TOMORROW + 2 FREE BonusesOver the last 37 years on Wall Street, I've developed a unique investing strategy that allows me to find stock...Unstoppable Prosperity | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biodexa Pharmaceuticals Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Biodexa Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
